BCM
SNDX icon

Bayesian Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bayesian Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,000
Closed -$370K – 935
2024
Q4 		$370K Buy
+28,000
New +$479K 0.05% 442
2024
Q1 		– Sell
-15,116
Closed -$327K – 1093
2023
Q4 		$327K Buy
+15,116
New +$232K 0.03% 478
2023
Q3 		– Sell
-17,669
Closed -$370K – 981
2023
Q2 		$370K Sell
17,669
-995
-5% -$20.7K 0.04% 485
2023
Q1 		$394K Sell
18,664
-1,700
-8% -$42.3K 0.05% 452
2022
Q4 		$518K Buy
20,364
+9,487
+87% +$221K 0.08% 353
2022
Q3 		$261K Buy
+10,877
New +$244K 0.05% 457

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return